Onyx Pharmaceuticals to Report Second Quarter 2013 Financial Results After Market on August 8, 2013
Conference Call and Webcast at 5:00 p.m. Eastern Time
(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 07/31/13 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it will report financial results for the second quarter 2013 ended June 30, 2013 after the market closes on Thursday, August 8, 2013. The company will host a webcast and conference call with management to discuss financial results, as well as provide a general business overview, at 5:00 p.m. ET (2:00 p.m. PT).
To access a live audio webcast of the conference call, log onto the company's website at: .
To access the live conference call, dial 847-585-4405 and use the passcode 35393849#. A replay of the call will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 35393849# approximately one hour after the conference call concludes through August 22, 2013.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at . Onyx Pharmaceuticals is on Twitter. Sign up to follow our Twitter feed (at)OnyxPharm at .
Nicole Keith
650-266-2123
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 31.07.2013 - 12:30 Uhr
Sprache: Deutsch
News-ID 283355
Anzahl Zeichen: 0
contact information:
Town:
SOUTH SAN FRANCISCO, CA
Kategorie:
Surgery & Treatments
Diese Pressemitteilung wurde bisher 240 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Onyx Pharmaceuticals to Report Second Quarter 2013 Financial Results After Market on August 8, 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
Onyx Pharmaceuticals, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
